0
Researchers have developed a new computational tool that can identify pathways related to diseases, including breast and prostate cancer, using single-nucleotide polymorphisms.
Researchers have developed a new computational tool that can identify pathways related to diseases, including breast and prostate cancer, using single-nucleotide polymorphisms.